LQF-92089-32625
2 vaccinations
3 coded responses
8 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 921 / CA
- Registered
- 2021-05-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-27
Dose 1 — Pfizer-BioNTech
-
2021-05-17
Dose 2 — Pfizer-BioNTech
-
2021-05-18
Registered in v-safe
-
2021-05-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-05-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-05-20
Survey response — days 1–6 daily, dose 2MedDRA: Night sweats — Feeling: Good · Site: ItchingFree text: Night sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-22
- 2021-05-24
-
2021-08-18
Survey response — 3 months, dose 2MedDRA: Abortion spontaneous, Ear infection, Eye infection — Feeling: Fair · Be unable to work or attend schoolFree text: Miscarriage, ear infections, eye infectionsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-15
Survey response — 6 months, dose 2MedDRA: Bacterial infection, Viral infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Viral and bacterial infectionsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-15
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-16
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-27 | Pfizer-BioNTech | |
| 2 | 2021-05-17 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-15 | Successful 2021-11-16 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Night sweats
Release 9 — 3 months, dose 2
Symptoms: Miscarriage, ear infections, eye infections
Release 10 — 6 months, dose 2
Symptoms: Viral and bacterial infections
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | · | ✓ |
| SD | Bacterial infection | · | · | ✓ |
| SD | Ear infection | ✓ | · | ✓ |
| SD | Eye infection | ✓ | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release